2-piperidone has been researched along with 3,5-bis(benzylidene)-4-piperidone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bandy, B; Das, S; Das, U; Dimmock, JR; Stables, JP | 1 |
| Chu, Q; Das, U; Dimmock, JR; Kawase, M; Sakagami, H; Selvakumar, P; Sharma, RK; Wang, Q | 1 |
| Anant, S; Awasthi, V; Lagisetty, P; Sahoo, K; Vilekar, P | 1 |
| Agashe, H; Awasthi, V; Lagisetty, P; Sahoo, K | 1 |
| Das, S; Das, U; Dimmock, JR; Gorecki, DK; Iwamoto, S; Kawase, M; Matsuta, T; Molnár, J; Sakagami, H; Serly, J; Umemura, N | 1 |
| Bandy, B; Das, U; Dimmock, JR; Helal, M; Islam, A; Nazarali, AJ | 1 |
| Alcorn, J; Das, U; Dimmock, JR; Hickman, MR; Lee, PJ; Leed, SE; Roncal, N; Sciotti, RJ; Singh, RS | 1 |
| Awasthi, S; Awasthi, V; King, C; Lagisetty, P; Vilekar, P | 1 |
| Baráth, Z; Csonka, Á; Das, U; Dimmock, JR; Molnár, J; Pati, HN | 1 |
| Balzarini, J; Das, U; De Clercq, E; Dimmock, JR; Hossain, M; Kawase, M; Sakagami, H; Umemura, N | 1 |
| Das, S; Das, U; Dimmock, JR; Doroudi, A; Hossain, M; Zhu, J | 1 |
| Aguilera, RJ; Amano, S; Borrego, EA; Chhikara, A; Das, S; Das, U; Dimmock, JR; Guerena, CD; Hernandez, CR; Roayapalley, PK; Sakagami, H; Satoh, K; Uesawa, Y | 1 |
12 other study(ies) available for 2-piperidone and 3,5-bis(benzylidene)-4-piperidone
| Article | Year |
|---|---|
N-Aroyl-3,5-bis(benzylidene)-4-piperidones: a novel class of antimycobacterial agents.
Topics: Animals; Anti-Bacterial Agents; Mice; Molecular Structure; Mycobacterium tuberculosis; Piperidones; Rats; Structure-Activity Relationship | 2008 |
3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; HL-60 Cells; HT29 Cells; Humans; Piperidones; Quantitative Structure-Activity Relationship | 2010 |
CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.
Topics: Adenocarcinoma; Antineoplastic Agents; Autophagy; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Piperidones; Structure-Activity Relationship | 2010 |
Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cyclodextrins; Disease Models, Animal; Drug Delivery Systems; Liposomes; Lung Neoplasms; Piperidones; Rats | 2011 |
Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Piperidones | 2012 |
Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.
Topics: Animals; Colonic Neoplasms; Glutathione; HCT116 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Piperidones; Reactive Oxygen Species | 2013 |
3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Resistance; Hep G2 Cells; Humans; Liver; Malaria; Malaria, Falciparum; Mice; Piperidones; Plasmodium berghei; Plasmodium falciparum | 2013 |
Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA).
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cell Line; Curcumin; Dendritic Cells; Dimerization; Mice; Pentetic Acid; Phagocytosis; Piperidones | 2014 |
1-[3-(2-Hydroxyethylsulfanyl)propanoyl]-3,5-bis(benzylidene)-4-piperidones: A novel cluster of P-glycoprotein dependent multidrug resistance modulators.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Mice; Piperidones; Protein Binding; Structure-Activity Relationship | 2016 |
Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasms; Piperidones; Structure-Activity Relationship | 2016 |
Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Crystallography, X-Ray; Dichloroacetic Acid; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Conformation; Piperidones; Quantitative Structure-Activity Relationship; Reactive Oxygen Species | 2020 |
Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity.
Topics: Antineoplastic Agents; Apoptosis; Carbon; Caspase 3; Cell Line, Tumor; Humans; Piperidones | 2022 |